This provider's $4.6M in total Medicare payments ranks in the 99th percentile of General Practice providers nationally.
This provider's billing patterns fall within normal ranges for their specialty.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $170.70 | $78.11 | 2.19x | $92.59 | $524.1K | 10.5K | 5.2K |
| 2015 | $170.91 | $77.59 | 2.20x | $93.32 | $591.4K | 11.1K | 5.6K |
| 2016 | $167.06 | $76.14 | 2.19x | $90.92 | $542.7K | 10.8K | 5.4K |
| 2017 | $177.38 | $75.00 | 2.37x | $102.38 | $450.5K | 9.1K | 4.9K |
| 2018 | $190.98 | $87.60 | 2.18x | $103.38 | $505.8K | 9.7K | 5.1K |
| 2019 | $174.75 | $86.00 | 2.03x | $88.75 | $497.6K | 9.9K | 5.2K |
| 2020 | $168.28 | $84.62 | 1.99x | $83.66 | $350.6K | 7.1K | 4.0K |
| 2021 | $185.80 | $98.37 | 1.89x | $87.43 | $390.3K | 6.6K | 4.0K |
| 2022 | $173.52 | $93.76 | 1.85x | $79.76 | $382.7K | 6.4K | 3.7K |
| 2023 | $185.66 | $97.32 | 1.91x | $88.34 | $375.4K | 6.3K | 3.5K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | 22.3K | $1.2M | $52.67 | 1.86x |
| 11100 | Biopsy of single growth of skin and/or tissue | 10.0K | $642.7K | $64.16 | 2.18x |
| 11102 | Tangential biopsy of single skin lesion | 8.2K | $541.7K | $66.16 | 2.31x |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 2.0K | $515.7K | $253.05 | 1.50x |
| 11103 | Tangential biopsy of additional skin lesion | 6.2K | $231.2K | $37.22 | 1.83x |
| 11101 | Biopsy of each additional growth of skin and/or tissue | 8.2K | $186.7K | $22.81 | 2.85x |
| 11901 | Injection of more than 7 skin growths | 3.7K | $148.2K | $39.58 | 2.02x |
| 96567 | Application of light to aid destruction of premalignant and/or malignant skin growths, each session | 1.5K | $136.2K | $91.20 | 3.02x |
| 17281 | Destruction of malignant growth (0.6 to 1.0 centimeters) of face, ears, eyelids, nose, lips, or mouth | 1.1K | $119.8K | $110.85 | 2.40x |
| 17262 | Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs | 922 | $100.2K | $108.63 | 2.13x |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 6.2K | $90.4K | $14.68 | 2.18x |
| 17282 | Destruction of malignant growth (1.1 to 2.0 centimeters) of face, ears, eyelids, nose, lips, or mouth | 530 | $73.7K | $139.11 | 2.33x |
| 69100 | Biopsy of ear | 1.7K | $62.5K | $36.43 | 3.98x |
| 96573 | Application of light and light-sensitive drugs to aid destruction of premalignant skin growths, per day | 429 | $62.2K | $145.09 | 2.24x |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 616 | $57.0K | $92.52 | 2.05x |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | 1.0K | $49.9K | $48.98 | 2.15x |
| 17261 | Destruction of malignant growth (0.6 to 1.0 centimeters) of trunk, arms, or legs | 628 | $48.4K | $77.03 | 2.65x |
| 11900 | Injection of up to 7 skin growths | 1.5K | $44.6K | $28.81 | 2.64x |
| 40490 | Biopsy of lip | 490 | $39.7K | $81.12 | 1.54x |
| 17272 | Destruction of malignant growth (1.1 to 2.0 centimeters) of scalp, neck, hands, feet, or genitals | 310 | $37.6K | $121.35 | 2.22x |
This provider submits charges 2.1 times higher than what Medicare actually pays.
A markup ratio of 2.1x means for every $100 Medicare pays, this provider initially charges $210. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data